Our study was conducted in the cardio-surgical department of a German university hospital (RWTH University Hospital, Aachen, Germany). The ethics committee (Ethikkommission der RWTH Aachen) approved the study (EK 151/90). Written informed consent was obtained from all patients prior to study enrolment.
Between January 2015 and December 2016, all patients who were planned for nonemergency coronary artery bypass graft (CABG) surgery, were screened. Exclusion criteria were: (1) peripheral artery disease (PAD) more than Fontaine grade II, (2) moderate to severe aortic stenosis or regurgitation, (3) moderate to severe mitral stenosis or regurgitation, (4) atrial fibrillation, (5) left ventricular ejection fraction <40%, (6) no accurate ultrasound window for TTE. Five hundred and seventy-two patients were screened and 107 patients were included in the study (Fig. 1). Patients’ data were prospectively entered to our institution’s electronic database.
LVEF, Left ventricular ejection fraction; PAD, Peripheral artery disease; TTE, transthoracic echocardiography.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.